PF-Atlas › Clinical Trials › NCT00510484
Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Pancrelipase Delayed Release · Phase 3
Registry ID
NCT00510484
Phase
Phase 3
Status
Completed
Drug / intervention
Pancrelipase Delayed Release
Sponsor
Solvay Pharmaceuticals
Start
2007-11
About this trial
Pancrelipase Delayed Release is evaluated in NCT00510484, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Solvay Pharmaceuticals. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00510484 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.